CN103142898B - 一种贲门失弛缓症术后用药的制备方法 - Google Patents
一种贲门失弛缓症术后用药的制备方法 Download PDFInfo
- Publication number
- CN103142898B CN103142898B CN201310107718.6A CN201310107718A CN103142898B CN 103142898 B CN103142898 B CN 103142898B CN 201310107718 A CN201310107718 A CN 201310107718A CN 103142898 B CN103142898 B CN 103142898B
- Authority
- CN
- China
- Prior art keywords
- parts
- brown
- parched
- medicine
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 201000000621 achalasia Diseases 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 208000000289 Esophageal Achalasia Diseases 0.000 title abstract description 6
- 206010030136 Oesophageal achalasia Diseases 0.000 title abstract description 6
- 240000009033 Lindernia ruellioides Species 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims abstract description 10
- 239000000341 volatile oil Substances 0.000 claims abstract description 10
- 244000183278 Nephelium litchi Species 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 238000001556 precipitation Methods 0.000 claims abstract description 4
- 238000005507 spraying Methods 0.000 claims abstract description 4
- 230000002980 postoperative effect Effects 0.000 claims description 14
- 229940079593 drug Drugs 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 11
- 239000007788 liquid Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 241000219780 Pueraria Species 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 3
- 238000011282 treatment Methods 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 12
- 239000000203 mixture Substances 0.000 abstract description 6
- 239000002775 capsule Substances 0.000 abstract description 4
- 235000004051 Aeschynomene indica Nutrition 0.000 abstract description 3
- 241000244987 Daiswa polyphylla Species 0.000 abstract description 3
- 244000302544 Luffa aegyptiaca Species 0.000 abstract description 3
- 241000218206 Ranunculus Species 0.000 abstract description 3
- 238000001035 drying Methods 0.000 abstract description 2
- 238000002474 experimental method Methods 0.000 abstract description 2
- 240000007594 Oryza sativa Species 0.000 abstract 3
- 235000007164 Oryza sativa Nutrition 0.000 abstract 3
- 235000009566 rice Nutrition 0.000 abstract 3
- 244000161999 Acacia greggii Species 0.000 abstract 2
- 241000483908 Aeschynomene sensitiva Species 0.000 abstract 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 240000005779 Jasminum multiflorum Species 0.000 abstract 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 2
- 235000015742 Nephelium litchi Nutrition 0.000 abstract 2
- 244000046146 Pueraria lobata Species 0.000 abstract 2
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 2
- 240000009022 Smilax rotundifolia Species 0.000 abstract 2
- 235000003205 Smilax rotundifolia Nutrition 0.000 abstract 2
- 235000004608 catclaw acacia Nutrition 0.000 abstract 2
- 239000002023 wood Substances 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 238000011049 filling Methods 0.000 abstract 1
- 238000000227 grinding Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 238000003809 water extraction Methods 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 12
- 210000003238 esophagus Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 108091006146 Channels Proteins 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 206010067171 Regurgitation Diseases 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000037803 restenosis Diseases 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 238000001839 endoscopy Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000002040 relaxant effect Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000002318 cardia Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- SGTNSNPWRIOYBX-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile Chemical compound C1=C(OC)C(OC)=CC=C1CCN(C)CCCC(C#N)(C(C)C)C1=CC=C(OC)C(OC)=C1 SGTNSNPWRIOYBX-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000144706 Aeschynomene indica Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 241000343262 Ternatus Species 0.000 description 1
- 241000983344 Trachelospermum jasminoides Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 229940125713 antianxiety drug Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000007963 capsule composition Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229960004166 diltiazem Drugs 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000002674 endoscopic surgery Methods 0.000 description 1
- 238000012277 endoscopic treatment Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 208000020985 infant symptom Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- MOYKHGMNXAOIAT-JGWLITMVSA-N isosorbide dinitrate Chemical compound [O-][N+](=O)O[C@H]1CO[C@@H]2[C@H](O[N+](=O)[O-])CO[C@@H]21 MOYKHGMNXAOIAT-JGWLITMVSA-N 0.000 description 1
- 229960000201 isosorbide dinitrate Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000007971 neurological deficit Effects 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 239000000050 smooth muscle relaxant Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229960001722 verapamil Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310107718.6A CN103142898B (zh) | 2013-03-31 | 2013-03-31 | 一种贲门失弛缓症术后用药的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310107718.6A CN103142898B (zh) | 2013-03-31 | 2013-03-31 | 一种贲门失弛缓症术后用药的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103142898A CN103142898A (zh) | 2013-06-12 |
CN103142898B true CN103142898B (zh) | 2014-07-30 |
Family
ID=48541407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310107718.6A Expired - Fee Related CN103142898B (zh) | 2013-03-31 | 2013-03-31 | 一种贲门失弛缓症术后用药的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103142898B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103893356B (zh) * | 2014-04-29 | 2015-10-28 | 杨献华 | 一种促进剖宫产术后胃肠功能恢复的药物组合物及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101874889B (zh) * | 2010-04-23 | 2012-05-23 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗脘痞的中药组合物及其制备方法 |
-
2013
- 2013-03-31 CN CN201310107718.6A patent/CN103142898B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101874889B (zh) * | 2010-04-23 | 2012-05-23 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗脘痞的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
中西医结合治疗胃手术后胀逆症;尹红等;《湖北中医学院学报》;20010920;第3卷(第03期);32 * |
尹红等.中西医结合治疗胃手术后胀逆症.《湖北中医学院学报》.2001,第3卷(第03期), |
Also Published As
Publication number | Publication date |
---|---|
CN103142898A (zh) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN102166278B (zh) | 一种治疗小儿类风湿性关节炎的中药组合物及其制备方法 | |
CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
CN102178781B (zh) | 一种治疗阴囊湿疹的中药组合物及其制备方法 | |
CN103142897B (zh) | 一种贲门失弛缓症术后用药 | |
CN103142898B (zh) | 一种贲门失弛缓症术后用药的制备方法 | |
CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
CN104825956A (zh) | 防治中风、康复筋骨关节的药 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
US20040241259A1 (en) | Herbal ointment and method for constipation treatment | |
CN117959394B (zh) | 参芪通脉制剂在制备防治糖尿病神经病变药物中的用途 | |
CN109731047A (zh) | 一种治疗椎间盘突出、骨质增生、风寒湿痹痛、颈肩腰腿痛的筋骨疼痛膏及制备方法 | |
CN101954018A (zh) | 一种治疗慢性肾炎的内服药物 | |
CN102018765A (zh) | 一种治疗糖尿病肢端坏死的中药 | |
CN103191335B (zh) | 一种治疗食道失弛缓症的药物组合物 | |
CN103191338B (zh) | 一种治疗小儿贲门失弛缓症的药物组合物 | |
CN103191339A (zh) | 一种治疗小儿贲门失弛缓症药物的制备方法 | |
CN103157040A (zh) | 一种治疗多发性骨软骨瘤的药物组合物 | |
CN103191337A (zh) | 一种食道失弛缓症术后用药的制备方法 | |
CN104825846A (zh) | 一种治疗面神经炎的中药组合物 | |
CN103142899A (zh) | 一种治疗脊柱骨骺发育不良药物的制备方法 | |
CN106177736A (zh) | 一种缓解肠胃不适引起便秘的艾叶保健茶及其制备方法 | |
CN103157043A (zh) | 一种食道失弛缓症术后用药 | |
CN103191340A (zh) | 一种骨软骨瘤的护理药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: JU WEIDONG Free format text: FORMER OWNER: ZHANG PENGFEI Effective date: 20140630 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Ju Weidong Inventor after: Zhao Hong Inventor after: Zhao Yongna Inventor after: Zhang Pengfei Inventor before: Zhang Pengfei |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: ZHANG PENGFEI TO: JU WEIDONG ZHAO HONG ZHAO YONGNA ZHANG PENGFEI Free format text: CORRECT: ADDRESS; FROM: 276826 RIZHAO, SHANDONG PROVINCE TO: 262200 WEIFANG, SHANDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140630 Address after: 262200 Zhucheng people's Hospital, 59 South Ring Road, Zhucheng, Shandong, Weifang, China Applicant after: Ju Weidong Address before: 276826 Rizhao City traditional Chinese medicine hospital, 35 Hai Lu, Shandong, Rizhao City Applicant before: Zhang Pengfei |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140730 Termination date: 20150331 |
|
EXPY | Termination of patent right or utility model |